1. Home
  2. PRPL vs KPTI Comparison

PRPL vs KPTI Comparison

Compare PRPL & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.65

Market Cap

76.9M

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$5.34

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
KPTI
Founded
2010
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
172.6M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
PRPL
KPTI
Price
$0.65
$5.34
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$1.00
$15.33
AVG Volume (30 Days)
223.0K
1.3M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
22.22
N/A
EPS
0.45
N/A
Revenue
$487,877,000.00
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.69
$46.62
P/E Ratio
$1.52
N/A
Revenue Growth
N/A
0.57
52 Week Low
$0.56
$3.51
52 Week High
$1.26
$10.99

Technical Indicators

Market Signals
Indicator
PRPL
KPTI
Relative Strength Index (RSI) 44.82 29.62
Support Level N/A $3.93
Resistance Level $0.73 $6.82
Average True Range (ATR) 0.05 0.86
MACD -0.01 -0.36
Stochastic Oscillator 50.50 9.41

Price Performance

Historical Comparison
PRPL
KPTI

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: